Rehovot, Israel

Liat Adar

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Liat Adar: Innovator in Parkinson's Disease Treatment

Introduction

Liat Adar is a prominent inventor based in Rehovot, Israel, known for her significant contributions to the field of neurology, particularly in the treatment of Parkinson's disease. With a total of five patents to her name, she has made remarkable strides in developing methods that aim to alleviate the symptoms of this debilitating condition.

Latest Patents

Among her latest patents, Liat Adar has disclosed innovative methods and compositions for reducing symptoms of Parkinson's disease. One of her notable inventions involves a method for treating neurological or movement disorders through the parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa or benserazide. Another significant patent outlines a method that combines parenteral administration of levodopa, a levodopa salt, or a levodopa prodrug with oral administration of DDCIs, providing a comprehensive approach to managing Parkinson's disease.

Career Highlights

Liat Adar is currently associated with Neuroderm, Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from Parkinson's disease.

Collaborations

Liat collaborates with talented professionals in her field, including her coworkers Tal Birnberg and Itay Perlstein, who contribute to her innovative projects and research initiatives.

Conclusion

Liat Adar's dedication to developing effective treatments for Parkinson's disease showcases her commitment to innovation in the medical field. Her patents reflect a deep understanding of neurological disorders and a desire to enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…